Literature DB >> 23176440

Postnatal lineage mapping of follicular melanocytes with the Tyr::CreER(T) (2) transgene.

Melissa L Harris1, William J Pavan.   

Abstract

One of the main advantages of using inducible and conditional transgenes to study pigment cell biology is that they allow for genetic manipulation within melanocytes after roles in general neural crest or melanoblast development have been fulfilled. Specifically, we focus here on the ability of the Tyr::CreER(T) (2) transgenic line to alter genes within follicular melanocytes postnatally. Using the Gt(ROSA)26Sor(tm1sor) reporter allele, we present in detail the expression and activity of Tyr::CreER(T) (2) when induced during hair morphogenesis and adult hair cycling. We find that despite similarities in expression pattern to endogenous TYR, Tyr::CreER(T) (2) is effective at targeting both undifferentiated and differentiated melanocytes within the hair follicle. We also find that Tyr::CreER(T) (2) provides the highest levels of recombination when induced during the early phases of hair growth. In conclusion, the descriptions provided here will guide future analyses of gene function within the melanocyte system of the hair follicle when using this Tyr::CreER(T) (2) transgene.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23176440      PMCID: PMC4034131          DOI: 10.1111/pcmr.12048

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN: 1755-1471            Impact factor:   4.693


  24 in total

Review 1.  A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages.

Authors:  S Müller-Röver; B Handjiski; C van der Veen; S Eichmüller; K Foitzik; I A McKay; K S Stenn; R Paus
Journal:  J Invest Dermatol       Date:  2001-07       Impact factor: 8.551

2.  Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Authors:  Olga Shakhova; Daniel Zingg; Simon M Schaefer; Lisette Hari; Gianluca Civenni; Jacqueline Blunschi; Stéphanie Claudinot; Michal Okoniewski; Friedrich Beermann; Daniela Mihic-Probst; Holger Moch; Michael Wegner; Reinhard Dummer; Yann Barrandon; Paolo Cinelli; Lukas Sommer
Journal:  Nat Cell Biol       Date:  2012-07-08       Impact factor: 28.824

3.  Generalized lacZ expression with the ROSA26 Cre reporter strain.

Authors:  P Soriano
Journal:  Nat Genet       Date:  1999-01       Impact factor: 38.330

4.  Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.

Authors:  A K Indra; X Warot; J Brocard; J M Bornert; J H Xiao; P Chambon; D Metzger
Journal:  Nucleic Acids Res       Date:  1999-11-15       Impact factor: 16.971

5.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

6.  SCF/c-kit signaling is required for cyclic regeneration of the hair pigmentation unit.

Authors:  N V Botchkareva; M Khlgatian; B J Longley; V A Botchkarev; B A Gilchrest
Journal:  FASEB J       Date:  2001-03       Impact factor: 5.191

7.  Characterization of melanocyte-specific inducible Cre recombinase transgenic mice.

Authors:  Marcus Bosenberg; Viswanathan Muthusamy; David P Curley; Zhenxiong Wang; Cara Hobbs; Betsy Nelson; Cristina Nogueira; James W Horner; Ronald Depinho; Lynda Chin
Journal:  Genesis       Date:  2006-05       Impact factor: 2.487

8.  A mouse model of melanoma driven by oncogenic KRAS.

Authors:  Carla Milagre; Nathalie Dhomen; Felipe C Geyer; Robert Hayward; Maryou Lambros; Jorge S Reis-Filho; Richard Marais
Journal:  Cancer Res       Date:  2010-06-01       Impact factor: 12.701

Review 9.  Metabolites of tamoxifen in animals and man: identification, pharmacology, and significance.

Authors:  V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1982       Impact factor: 4.872

10.  Cochlear disorder associated with melanocyte anomaly in mice with a transgenic insertional mutation.

Authors:  M Tachibana; Y Hara; D Vyas; C Hodgkinson; J Fex; K Grundfast; H Arnheiter
Journal:  Mol Cell Neurosci       Date:  1992-10       Impact factor: 4.314

View more
  3 in total

1.  DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR.

Authors:  Goran Micevic; Viswanathan Muthusamy; William Damsky; Nicholas Theodosakis; Xiaoni Liu; Katrina Meeth; Emily Wingrove; Manjula Santhanakrishnan; Marcus Bosenberg
Journal:  Cell Rep       Date:  2016-02-25       Impact factor: 9.423

2.  The APC/C E3 Ligase Complex Activator FZR1 Restricts BRAF Oncogenic Function.

Authors:  Lixin Wan; Ming Chen; Juxiang Cao; Xiangpeng Dai; Qing Yin; Jinfang Zhang; Su-Jung Song; Ying Lu; Jing Liu; Hiroyuki Inuzuka; Jesse M Katon; Kelsey Berry; Jacqueline Fung; Christopher Ng; Pengda Liu; Min Sup Song; Lian Xue; Roderick T Bronson; Marc W Kirschner; Rutao Cui; Pier Paolo Pandolfi; Wenyi Wei
Journal:  Cancer Discov       Date:  2017-02-07       Impact factor: 39.397

3.  A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors.

Authors:  Melissa L Harris; Kristina Buac; Olga Shakhova; Ramin M Hakami; Michael Wegner; Lukas Sommer; William J Pavan
Journal:  PLoS Genet       Date:  2013-07-25       Impact factor: 5.917

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.